Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Addition of SM-20302 to tPA associated with beneficial outcome in thromboembolic stroke

Feb. 8, 2002

Inhibitors of factor Xa described in patent by Cor Therapeutics

Feb. 4, 2002

Factor Xa-inhibitory lactams disclosed by Bristol-Myers Squibb

Feb. 4, 2002

Bivalirudin reduces both thrombotic and bleeding complications in acute coronary syndromes

Feb. 4, 2002

Integrin receptor inhibitors identified at Merck KGaA

Feb. 1, 2002

Schering-Plough discloses use and preparation of thrombin and CB2 receptor antagonists

Feb. 1, 2002

Aventis synthesizes urea and thiourea derivatives as inhibitors of factor VIIa

Jan. 22, 2002

Anticoagulants derived from phenylglycine at Roche

Jan. 18, 2002

CSL obtains marketing and distribution license to Angiomax in Australia

Jan. 10, 2002

Emisphere completes enrollment in PROTECT trial of oral heparin

Jan. 9, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...
Grace Therapeutics hits CRL setback with GTx-104 despite positive trial
BioWorld
Grace Therapeutics Inc.’s hopes of becoming the first company in decades to update the standard of care in aneurysmal subarachnoid hemorrhage were delayed after...